Treatment of stage I hypertension and development of renal dysfunction

Journal of Human Hypertension

Volumn 15, Issue 2, 2001, Pages 81-84

  Bakris, G L ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Renal dysfunction; Stage 1 hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; RAMIPRIL;

ARTERIAL PRESSURE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DIET; DISEASE CLASSIFICATION; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DISEASE; LIFESPAN; LONG TERM CARE; META ANALYSIS; MORBIDITY; MORTALITY; NOTE; PROTEIN BLOOD LEVEL; TARGET ORGAN; TREATMENT OUTCOME;

EID: 0035113247     PISSN: 09509240     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.jhh.1001135     Document Type: Note

References (26)

1. Blood pressure, systolic and diastolic and cardiovascular risks
2. Blood pressure and end-stage renal disease in men
3. Early predictors of 15 year end stage renal disease in hypertensive patients
4. Joint National Committee Report on the Diagnosis and the Treatment of Hypertension (JNC-VI)
5. Treatment of hypertension in patients with renal disease
6. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes
7. ACE inhibitor associated elevations in serum creatinine: Is this a cause for concern?
8. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised controlled trials
9. Microalbuminuria: Prognostic implications
10. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men
11. Proteinuria as a mediator of tubulointerstitial injury
12. End stage renal disease in African-American and white men
13. Achievement and safety of a low blood pressure goal in chronic renal disease. The Modification of Diet in Renal Disease Study Group
14. African American Study of Kidney Disease and hypertension (AASK) - Clinical trial update
15. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators
16. Preserving renal function in adults with hypertension and diabetes: A consensus approach
17. Benefits of combination angiotensin-converting enzyme inhibitor and calcium antagonist therapy for diabetic patients
18. Randomized placebo controlled trial of effect of Ramipril on decline in glomerulor filtration rate and risk of terminal renal failure in proteinuric, non diabetic nephropathy
19. Effect of angiotensin converting enzyme inhibitor benaxepril on the progression of chronic renal insufficiency
20. Antiproteinuric effect of blood-pressure-lowering agents: A meta-analysis of comparative trials
21. Are angiotensin converting enzyme inhibitors superior to beta blockers in retarding progressive renal function decline
22. Randomised controlled trial of enalapril and β blockers in non-diabetic chronic renal failure
23. Long term effects of antihypertensive agents on proteinuria and renal function
24. The 1999 Canadian recommendations for the management of hypertension. On behalf of the Task Force for the Development of the 1999 Canadian Recommendations for the Management of Hypertension
25. Aggressive blood pressure control may eliminate racial disparity in hypertensive renal disease
26. Tight blood pressure control and risk of macrovascular and microvascular complications in type II diabetes; UKPDS 38